POORLY DIFFERENTIATED THYROID CARCINOMA
Clinical trials for POORLY DIFFERENTIATED THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new POORLY DIFFERENTIATED THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for POORLY DIFFERENTIATED THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive thyroid cancer: drug combo trial opens
Disease control Recruiting nowThis study tests two drugs—sacituzumab tirumotecan alone or with tislelizumab—in people with advanced thyroid cancer that cannot be removed by surgery or has spread. The goal is to see if these treatments can shrink tumors or help people live longer. About 94 adults with specific…
Matched conditions: POORLY DIFFERENTIATED THYROID CARCINOMA
Phase: NA • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [177Lu]Lu-AKIR001, in 15 adults with advanced solid tumors (like thyroid, head and neck, cervical, vulvar, or lung cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and sid…
Matched conditions: POORLY DIFFERENTIATED THYROID CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated May 17, 2026 02:56 UTC